Sonia Victoria Del Rincón

8PUBLICATIONS
75CO-AUTHORS
Medical virologyMolecular targetsRespiratory diseasesCancer diagnosisMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway.

|Feb 18, 2026
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Raúl E Flores-González, Christophe Goncalves, Noah Wirasinghe

|Dec 29, 2025
The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Madelyn J Abraham, Cynthia Guilbert, Natascha Gagnon

|Dec 26, 2024
Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies.

Georgia Mitsa, Livia Florianova, Josiane Lafleur

|Nov 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.

Cristiano Ferrario, John Mackey, Karen A Gelmon

|Sep 13, 2024
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Samuel E J Preston, Michael S Dahabieh, Raúl Ernesto Flores González

Pageof 2

Frequent Collaborators

5 joint publications

Wilson H Miller

3 joint publications

Samuel Preston

3 joint publications

Elizabeth M Guettler

3 joint publications

Christoph H Borchers